Brain derived neurotrophic factor mediated learning , fear acquisition and extinction as targets for developing novel treatments for anxiety

Anxiety and obsessive-compulsive related disorders are highly prevalent and disabling disorders for which there are still treatment gaps to be explored. Fear is a core symptom of these disorders and its learning is highly dependent on the activity of the neurotrophin brain-derived neurotrophic factor (BDNF). Should BDNF-mediated fear learning be considered a target for the development of novel treatments for anxiety and obsessive-compulsive related disorders? We review the evidence that suggests that BDNF expression is necessary for the acquisition of conditioned fear, as well as for the recall of its extinction. We describe the findings related to fear learning and genetic/epigenetic manipulation of Bdnf expression in animals and BDNF allelic variants in humans. Later, we discuss how manipulation of BDNF levels represents a promising potential treatment target that may increase the benefits of therapies that extinguish previously conditioned fear.


INTRODUCTION
Anxiety disorders, such as generalized anxiety disorder (GAD), social phobia (SoPh), post-traumatic stress disorder (PTSD), panic disorder (PD), and obsessive-compulsive and related disorders (OCRD), are amongst the most prevalent mental disorders worldwide and are frequently associated with high disability and impaired quality-of-life 1,2 .Pharmacotherapy with anxiolytics or antidepressants and disorder-oriented psychotherapy are the best evidence-based treatments for most anxiety disorders and OCRD 3 .However, these interventions have not yet been able to overcome much of the burden related to these disorders.Treatment interventions usually require long-term maintenance, and may not be suitable or available for a significant proportion of patients 4,5 .These unmet needs regarding anxiety and OCRD make the investigation of new treatment targets necessary.Since fear and anxiety are the core symptoms of most anxiety and OCRD, it is likely that new targets are located at the systems that control these emotional manifestations 6 .
Fear and anxiety encompass similar physiological responses -tachycardia, hyperventilation, increased sweating, and tremor -and cognitive experiencesrepetitive thoughts about putative threatening situations or disasters.However, these concepts differ regarding their temporal relationship with threat: while fear represents the immediate response to current threat and fight-or-flight reactions, anxiety is related to the process of anticipation of future threat and avoidance 7,8 .Learning what to fear and what not to fear or avoid is a dynamic process that occurs along the lifespan and that is highly adaptive to different environments.Nonetheless, fear and anxiety can be displaced or exaggerated, as in the case of anxiety disorders and OCDR; thus anxiety disorders and OCDR are being hypothesized as disorders of fear learning.
One of the possible ways by which we learn that a stimulus is menacing is through fear conditioning 9 .Fear conditioning requires a neutral stimulus (e.g.light, sound, or location) to be repeatedly presented preceding an aversive unconditioned stimulus (US) (e.g.shock, sudden loud sound, painful stimulus).Through classic conditioning, the initially neutral stimulus acquires the ability to trigger the fear response, becoming a conditioned stimulus (CS) with properties that resemble those of the US 10 .Once the fear response is learned, it can be extinguished by the repeated presentation of the CS not followed by the US 11 .The concepts of fear conditioning and extinction are represented in Figure 1.
The extinction of fear responses is the main concept that underlies many psychotherapeutic protocols specifically developed for the treatment of anxiety and OCRD, e.g.exposure and response prevention for OCD 12,13 , social exposure for SoPh 14 and prolonged exposure for PTSD 15 .The behavioral framework that underlies the use of exposure therapy for anxiety disorders is represented in Figure 2. According to this framework, individuals with resistance to extinction or who do not retrieve the previously learned extinction should be more prone to develop anxiety and resistance to treatment 16 .
Fear learning requires memorization processes such as activity-dependent long-term potentiation (LTP) 17 .Together with other neurotrophins, brain-derived neurotrophic factor (BDNF) is a protein that regulates activity-dependent neuronal modifications and promotes neuronal proliferation, differentiation, survival and death during central nervous system (CNS) development 18 .
BDNF synthesis occurs from a precursor form, the pro-BDNF.After transcription in the endoplasmic reticulum, pro-BDNF is packaged into secretory vesicles by Golgi apparatus.Through the action of proteases, most of them in extracelular space, prodomain is cleaved from pro-BDNF, releasing mature domains.In response to extracellular and intracellular signals, BDNF secretion occurs at both pre-and postsynaptic sites.BDNF is released into different pathways that can be either constitutive or regulated (that secretes BDNF in response to neuronal activity) 19 .

BDNF, fear and anxiety
BDNF actions occurs by binding and activating the tropomycin receptor kinase B or TrkB.BDNF binds to TrkB receptors located on presynaptic and postsynaptic sites, leading to the activation of signal transduction pathways, including mitogen activated protein kinase/extracellular signal-regulated protein kinase (MAPK/ERK), phospholipase Cγ (PLCγ), and phosphoinositide 3-kinase (PI3K) pathways 20 .Activation of BDNF/TrkB signaling causes phosphorylation of other receptors (e.g.glutamate receptors, AMPA and NMDA), increase in neurotransmitter release from presynaptic sites, enhancement of protein synthesis, axon growth, and neuronal differentiation, proliferation and survival 21 .
Several studies have demonstrated that BDNF plays a role in regulating neural structure and function by participating in short-term synaptic plasticity and early and late LTP 22 .Such processes are of fundamental importance for learning and memory consolidation 23 , which are, in turn, responsible for the long-term effects of environmental stimuli, such as stressful life events.For its participation in LTP processes during fear learning, BDNF has been hypothesized as a possible target for the development of interventions that may improve fear extinction.
Our aim was to review the current literature and to understand how interventions that directly or indirectly interfere with BDNF levels became potential treatments for anxiety and OCRD and how we should guide future research.

METHODS
To prepare for this manuscript, a literature search was performed in July 2015 using the PubMed and Embase databases for articles that contained the terms "brain-derived neurotrophic factor", AND "learning" AND "fear" as words from the title or abstract, no limit for date of publication was specified.In total, the initial search resulted in 87 articles.Two researchers independently examined the list of abstracts and excluded articles for which access to full-text (abstracts published in annals of congresses) was not available or in which an experiment that directly evaluated BDNF genetic variants, BDNF plasma/serum levels or expression was absent.The reference lists from the 71 remaining articles and reviews were checked for additional original articles on the subject.Thirteen articles were classified as reviews and presented no original data.Two article presented original data concerning BDNF manipulation, but did not assess any direct or indirect measure of fear and one study investigated the effects of BDNF on appetitive learning.The articles retrieved in the search that evaluated BDNF mediated fear learning directly are described in the text.Additional studies retrieved in the search but not directly related to the subject are briefly described in Table 1.
Oliveira KS et al.

RESULTS
So far, animal studies comprise the majority of research on BDNF and fear conditioning.Since BDNF expression was consistently proven to change according to learning paradigms 24 , several methods have been applied to manipulate BDNF levels and its effects.In the last decades, knockout animals carrying a defective allele of the Bdnf gene, exposure to environmental factors that are known to alter BDNF expression, the investigation of functional Bdnf allelic variants and the use of BDNF agonists have led to consistent replication of results regarding effects of BDNF on fear acquisition and extinction.Below, we summarize the main results regarding fear learning and BDNF according to different experimental procedures.Experiments of fear learning in rodents vary widely.While some experiments directly investigate fear conditioning and extinction through pairing of neutral and aversive stimulus, others investigate spatial learning and working memory through fear-related learning tasks such as the acquired ability to find the easiest way out of a trap (e.g.: Morris water maze).In addition, the fear conditioning

BDNF, fear and anxiety
experiments may also vary regarding the type of CS.Some experiments use cues while others use context (a specific location).The neuronal pathway activated during these different types of learning experiments is not identical; therefore, small experimental variations may lead to divergent results.In addition, the complexity of multi-level molecular regulation of BDNF is not completely understood.Small variations in the methodology applied to interfere with BDNF transcription may also result in divergent findings.

Hippocampus
Liu et al. tested the fear conditioning characteristics of Bdnf heterozygous knock-out mice and demonstrated that contextual fear learning (i.e., when a location functions as CS) but not cued fear learning (tone footshock pairing) was impaired compared to controls.In a second experiment, infusion of the recombinant Bdnf protein into the hippocampal formation was able to revert the impairment in contextual learning 25 .These authors did not investigate extinction retention of the fear response in Bdnf heterozygous mice.Heldt et al. 26 , on the other hand, injected a lentivirus expressing Cre-recombinase to promote the site-specific deletion of Bdnf in the dorsal hippocampus of adult mice.The hippocampal deletion of Bdnf led to impairment in object recognition, spatial learning (as demonstrated with the Morris water maze) and extinction of conditioned fear with an auditory cue (demonstrated by higher fear-potentiated startle and freezing in the end of the extinction session), although no effects were observed in the acquisition or expression of fear response.Differently from Liu et al.'s study, Heldt et al. did not evaluate the effects of contextual fear learning.In addition, when deleting Bdnf from the hipoccampus of adult mice, Heldt et al. aimed to evaluate the acute effects of hipoccampal Bdnf loss and differentiate those effects from the developmental effects of general lower Bdnf levels that are inherent to experiments with Bdnf heterozygous knock-out mice.
When comparing mutant mice with a selective disruption of activity-dependent Bdnf expression to not genetically manipulated mice, Sakata et al. 27 showed that mutant mice are more prone to behavioral perseveration, including perseveration of conditioned fear responses due to impairment in extinction retention.Those animals exhibited selective impairment of Bdnf-dependent but not Bdnf-independent late LTP in the hippocampus.
In summary, constitutive lower levels of Bdnf were associated with impaired contextual fear learning and this effect was reverted by injecting Bdnf in the hipoccampus.Acute Bdnf blocking (regulated pathway) in the hippocampus was associated with impaired extinction of cued fear learning.
Similarly, extinction of cued fear learning was disrupted in animals with a mutation that specifically reduced acitivitydependent (but not constitutive) Bdnf expression.These same animals have been proven to show impaired late LTP in the hipoccampus.In different experiments, the constitutive effects of Bdnf in the hippocampus have been associated with learning deficits during contextual fear conditioning while activity-dependent and acute Bdnf effects have been associated with deficits of cued fear extinction.

Amygdala
Methods of manipulation of the Bdnf receptor known as TrkB allow the investigation of localized interruption of Bdnf signaling and the isolation of Bdnf effects on the amygdala.Chhatwal et al. 28 investigated the effect of Bdnf in the formation of extinction memory manipulating TrkB in the basolateral nucleus of the amygdala (BLA) through a viral gene-delivery system.Infected neurons express a truncated and inactive form of the TrkB receptor (TrkB.t1).Rats expressing TrkB.t1 in the BLA were unable to consolidate memory of the extinction training despite showing similar fear extinction compared to controls.
Rattiner et al. 29 used both the viral gene-delivery system of TrkB.t1 and a TrkB receptor blockade to examine the role of TrkB on amygdala-dependent learning and memory.With the inhibition of TrkB in the amygdala by either methods, rats became unsusceptible to acquisition and memory of fear conditioning although the expression of fear was not impaired.The association between effects of Bdnf on the amygdala and fear extinction was not tested.
Similarly, administration of the TrkB ligand scavenger, TrkB IgG and a Trk-specific tyrosine kinase inhibitor in the amygdala of rats impaired fear memory 30 .Differently from the effects of blocking Bdnf acute action in the hippocampus, interference with the action of Bdnf in the amygdala inhibits the acquisition and consolidation of cued conditioned fear 29 .
When extinction takes place, a new memory is formed and it competes with the preceding memory of acquisition, during recall.Previous studies -that were not among the articles retrieved in the search for this review for not being related to BDNF/Bdnf activity -had already described that the mechanism of extinction retention is dependent on the activation of the ventromedial prefrontal cortex (vmPFC) during memory recall of extinction both in rodents 31 and humans 32 .The vmPFC of the human brain is homologue to the infralimbic cortex of the rodent brain.The abbreviation vmPFC will be used to refer to both species.The vmPFC is responsible for maintaining extinction during recall but depends on the activation of the hippocampus 32 .Blocking Bdnf in the hippocampus, during extinction, may interfere with the activation of the vmPFC during recall resulting in loss of the extinction learning.The schematic representation of these hypotheses is represented in Figure 3.

Manipulation of differential Bdnf expression and epigenetic mechanisms
The Bdnf gene has multiple Bdnf mRNA transcripts that code the same protein, which suggests multilevel regulation of its expression.Despite coding the same protein, specific transcript isoforms can regulate trafficking and targeting of the mRNA.In addition to transcript isoforms, epigenetic mechanisms such as histone acetylation and DNA methylation may contribute to ongoing regulation of Bdnf in the CNS.The following articles describe how the interference with regulatory mechanisms can impact memory consolidation of fear acquisition and extinction.Such findings are of interest because they show how the use of substances or activities that interfere with epigenetic mechanisms may impact fear acquisition and extinction without any direct manipulation of BDNF/Bdnf protein of BDNF/Bdnf DNA coding.

Bdnf transcripts
Rattiner et al. 33 studied the expression of Bdnf multiple transcripts: 5'-exons (I-IV) and 3'-exon (V).Rats were submitted to light-shock pairings for conditioning fear and killed 2 hours afterwards.Analysis of their amygdala demonstrated an increase in transcripts containing exons I, III and V, while the amount of transcripts containing exons II and IV was similar to that verified in controls not submitted to the fear conditioning paradigm.This suggests that behavioral changes may be the result of differential regulation of Bdnf promoters 33 .
Barnes and Thomas 34 have shown that hippocampal injection of an inhibitor of proteolysis of the proBdnf protein precludes the acquisition and extinction of contextual fear memory.Additional evidence of differential expression of Bdnf promoters include findings from McDowell et al. 35 that found that knockout mice for the transcriptional factor known as Calcium-Response Factor expressed exclusively the exon IV and presented reduced total levels of Bdnf 35 ; and from Preethi et al. 36 who demonstrated that rats treated with Bacopa monniera (a medicinal Ayurvedic herb known as a neural tonic and memory enhancer) showed up-regulated Bdnf exon IV transcripts in the hippocampus and improved contextual fear memory consolidation.

Histone acetylation
Several studies evaluated the relationship of fear learning with epigenetic mechanisms that interfere with differential Bdnf expression.Bredy et al. 37 have shown that fear conditioning is regularly followed by increases in histones H3 and H4 acetylation around the P1 and P4 promoters of Bdnf, respectively.In addition, the extinction procedure was followed by an increase in exons I and IV of Bdnf mRNA.Using valproic acid (VPA), a histone deacetylase inhibitor, the authors evaluated the effects on Bdnf expression following behavioral training.Compared with controls that were injected with valpromide, an analogue of VPA that shares its anticonvulsant and mood stabilizing effects but is not a histone deacetylase inhibitor, mice that were injected with VPA prior to training showed enhanced and dosedependent long-term memory for extinction.Furthermore, an increase in acetylation following extinction was observed only in histone H4, around P1 and P4 Bdnf promoters.Only transcripts containing exon IV were elevated.These findings suggest an association between histone H4 acetylation and the extinction of conditioned fear 37 .

DNA methylation
Lubin et al. 38 demonstrated that regulation of Bdnf through epigenetic mechanisms also occurs during contextual fear memory consolidation.The authors observed an increase in exon IV containing transcripts in the hippocampus and active demethylation of exon IV following fear conditioning.To evaluate how much decreased DNA methylation alters Bdnf transcription, the effect of DNA methyltransferases (DNMT), which regulates de novo or maintenance of methylation at CpG island sites within DNA was examined.Memory consolidation was assessed 24 hours after DNMT inhibition and less freezing was observed in the experimental group, suggesting that regulation of DNA methylation is necessary for memory consolidation 38 .

Confirmatory findings for histone acetylation and DNA methylation
Following the same line of research, Sui et al. 39 demonstrated that rats that received stimulation of the vmPFC have increased levels of total DNMT, total histone acetyltransferases, and global acetylated histones H3 and H4 following stimulation.

BDNF, fear and anxiety
The use of inhibitors of the enzymes that control methylation/demethylation precluded demethylation and acetylation of the Bdnf and the process of LTP 39 .
In summary, differential exon usage in the hippocampus relates to transcriptional control of Bdnf.Prior findings in the amygdala suggest that site-specific initiation of transcription of Bdnf might be used to signal salient features of environmental cues.In addition, the multiple Bdnf mRNA transcripts have been shown to be sensitive to epigenetic modification through histone acetylation and DNA methylation.These epigenetic mechanisms are, in turn, dynamically involved in memory consolidation.
Taken together, these results highlight that transcription regulation varies according to environmental conditions and that histone acetylation and DNA methylation can be potent transcription control mechanisms even in non-dividing cells.The significance of Bdnf differential regulation is, however, not completely understood.It could be that the only function of differential exon usage is for differential transcriptional control.Notwithstanding, it is still possible that differential regulation relates to function.
As well, processes that increase or reduce acetylation and methylation might impact memory consolidation of fear acquisition or extinction if they take place during the learning phase.In the future, a better understanding of those processes might provide clues about interventions that have the potential to reduce the consolidation of fear memories or to promote the consolidation of extinction memories.

Bdnf genetic variants in humans
Some BDNF allelic variants have been shown to interfere with gene expression 40 .There are two main functional variants 41 : the BDNF-linked complex polymorphic region (LCPR-BDNF), a microsatellite polymorphism associated with lower transcription levels of the protein; and the val66met that refers to the substitution of valine for methionine at one prodomain of the BDNF protein.Heterozygotes (Metcarriers) for the val66met variation affect approximately 20 to 30% of the Caucasian population, while homozygotes (Met-Met-carriers) affect only 2 to 3% 42 .
Hajcak et al. 43 described that the Val66Met genotype is associated with impaired fear conditioning in healthy humans.Fear was conditioned by pairing rectangles of different sizes with a mild shock.Met-carriers showed a deficit in the startle response to the rectangle that was paired with the shock 43 .In another study with different methodology, Met-carriers also showed a behavioral deficit in fear conditioning.Pictures of male faces were used as stimuli and fear learning was quantified by skin conductance responses (SCR) and fear potentiated startle (FPS).Learning deficits were indicated by an absence of FPS responses during stimuli presentation after conditioning 44 .Later, the same group 45 replicated this finding and evaluated the fear response pattern of neural activation by functional MRI.As in the former study, Met-carriers showed deficits in fear conditioning.In addition, Met-carriers had heightened amygdala activation during conditioning according to functional neuroimaging.The authors then suggested that the Val66Met genotype could have a protective effect on the development of anxiety disorders mediated by reduced synaptic plasticity induced by negative experience 44 .
Another recent study on BDNF val66met polymorphism in humans, showed that Met-carriers are more likely to generalize context-dependent fear responses to novel (otherwise safe) contexts 46 .The interpretation of these findings was the opposite of the studies described earlier: that Met-carriers are more (not less) vulnerable to develop anxiety disorders.
A study conducted both in mice and in humans also investigated the effects of the presence of Bdnf/BDNF val66met SNP in fear conditioning.In both Met-carrier knock-in mice and human Met-carriers, the behavioral response during fear conditioning was not significantly different from the respective control groups.However, both showed impairments in the process of extinction of the conditioned fear response according to measurements of freezing behavior in mice and the variation in skin conductance in humans.Low levels of c-Fos (a protooncogene of Fos family of transcription factors) were verified in the vmPFC of Met-carrier mice.In human Met-carriers, a decrease in activation of the vmPFC was observed compared with non-Met-carriers, according to data from fMRI 47 .
These apparently contradictory findings regarding the val66met genotype in humans point toward the complexity of the interaction between BDNF mediated learning mechanisms and the consolidation of fear memories.It is not as simple as looking for the genetic variant that predisposes to anxiety through enhancement of fear learning or the one that is protective by increasing consolidation of extinction memories.When evaluating allelic variations, we have some background information about constitutive pathways involving BDNF but we still ignore much of allelic variations impact on regulatory pathways that may use redundant mechanisms not BDNF-dependent.Therefore, the effects of BDNF allelic variations have to be considered under dynamic and multifactorial conditions.

Bdnf/BDNF agonists
The use of Bdnf receptor agonists was shown to relieve animals from fear learning deficits possibly related to diminished Bdnf expression.Zeng et al. 48have shown that chronic treatment with a Bdnf receptor agonist improves both contextual and cued fear-related learning in aged rats.Andero et al. 49  agonist enhanced fear conditioning and extinction learning and rescued mice with a history of immobilization stress from fear extinction deficits.Based on these results, some researchers raised the hypothesis that using BDNF agonists could restore fear extinction in patients who cannot recall extinction learning following traumatic experiences.The use of BDNF itself in humans was investigated in previous trials, but initial results proved negative, possibly due to its plasma instability 50 .Therefore, the use of BDNF agonists instead of BDNF itself is a promising alternative.Notwithstanding, so far, there is no information from clinical trials to support this hypothesis.
Additional studies that indirectly evaluated the relationship between BDNF and fear learning are described briefly in Table 1.

DISCUSSION
The recent literature provides a complex picture of how BDNF expression interferes with acquisition and extinction of conditioned fear.There are several pathways that share, as a common end point, alterations in BDNF expression or differential splicing, suggesting that several mechanisms may interfere with fear memory acquisition and extinction through BDNF.Hence, to understand the impact of alterations of BDNF on fear and anxiety, we have to consider BDNF as part of a chain of multiple dynamically interacting variables that determine the likelihood of maintaining or extinguishing a fear memory 86 .
The effects of BDNF on fear memory and its repercussions are not straightforward.Increased BDNF expression can reinforce the consolidation of both fear acquisition and fear extinction with opposite consequences.Scientists disagree regarding the effect, for example, of the val66met BDNF polymorphism on vulnerability for anxiety disorders.While some believe that the Met-carrier genotype can be protective 44,45 , others believe the same genotype increases the likelihood of anxiety disorders 46,47 .Those who advocate for the protective role of the Met-carrier genotype consider its effects on conditioned fear while those who believe in its prejudicial effect are based on its role over fear extinction.
In humans, further research is necessary to confirm the preliminary findings of the prejudicial effect of the Metcarrier genotype for the val66met BDNF polymorphism on cognitive-behavior psychotherapy for PTSD 87 .It is still unclear if patients carrying such mutation would require additional interventions to improve extinction due to an intrinsic resistance to exposure treatment.Other genetic variants and environment manipulations may interfere with extinction but the information is still scarce for human subjects.
The broad participation of BDNF in processes related to fear acquisition and extinction makes it a reasonable target for new anxiety treatments.The use of BDNF agonists is currently under investigation at the pre-clinical level.Should the use of agonists prove useful, the greatest challenge will be determining under what circumstances the use of BDNF improves fear extinction.
Beyond BDNF agonists, other interventions have the potential to alter BDNF expression indirectly.Physical exercise, for example, increases BDNF expression in the hippocampus, which is critically involved in memory processes 88,89 .Augmentation of the effects of exposure therapy with physical exercise has been tested in PTSD patients with promising results 90 .Longer and bigger trials are still necessary to confirm these initial positive findings.
Of note, the use of antidepressants also increases BDNF expression and the activation of its receptor TrkB in animal models 91,92 .The effect of antidepressants as enhancers of fear extinction, however, is still matter of debate.Some animal studies found facilitated extinction or extinction retention with chronic use of antidepressants [93][94][95] albeit it has not been always replicated 96 perhaps due to sex-related differences 97 .One small human study found that chronic use of antidepressants may enhance extinction although it is not clear that the BDNF pathway is the one responsible for such effects 98 .

CONCLUSION
In summary, direct or indirect manipulations of BDNF levels or TrkB receptor activity are promising strategies to enhance the effect of fear extinction and less likely to diminish the effect of fear acquisition through conditioning.For its effects over extinction, the impact of manipulations of BDNF levels is highly related to the context in which such manipulations occur.Therefore, future trials will probably be directed at the investigation of methods that may enhance psychotherapy techniques that encompass exposure.

INDIVIDUAL CONTRIBUTIONS
Karina Soares de Oliveira -Performed the research and article compilation for this review and wrote the manuscript in its current format.
Juliana Belo Diniz -Provided the original idea that led to this review, wrote most of the content related to the relationship between anxiety and experimental manipulations of fear and reviewed the last version of this manuscript.

Figure 1 .
Figure 1.Schematic representation of the fear conditioning phenomena.US: unconditioned stimuli.

Figure 2 .
Figure 2. Schematic representation of the putative maintenance mechanism of conditioned fear responses.

Figure 3 .
Figure 3. Schematic representation of the brain regions related to fear conditioning and extinction.vmPFC: ventromedial pre-frontal cortex; BDNF: brain-derived neurotrophic factor.

Table 1 .
Additional studies that evaluated BDNF-related mechanisms of fear learning Animals (Mice) Fmr1 knockout mice, an animal model of Fragile X Syndrome, showed declined age-related BDNF levels in the hippocampus and impairment of contextual fear learning Kleschevnikov et al. (2012) 65 Animals (Mice) Treatment with two different GABAB receptor antagonists increased hippocampal levels of BDNF and restored memory of novel place recognition in a genetic model of Down syndrome 66agi et al. (2011)66Animals (Mice) BDNF levels were increased in the cortex, striatum and olfactory bulb of knock-out mice for the heparin-binding epidermal growth factor-like growth factor gene.These knock-out mice showed impairments in spatial memory and fear learning Kimura et al. (2010) 67 Animals (Mice) Both BDNF and TkrB levels were reduced in the hippocampus of heterozygous β-Site amyloid precursor protein cleaving enzyme 1 gene knock-out mice, which is an animal model for Alzheimer's disease Jin et al. (2009) 68 Animals (Mice) By modulating BDNF and the expression of other factors, fustin flavonoid attenuated amyloid-beta peptide-induced impaired learning Treadmill exercise training transiently increased the BDNF expression in the hippocampus and persistently increased hippocampal levels of TrkB and phosphorylated TrkB.These alterations were positively correlated with passive avoidance performance Early-onset forebrain-restricted BDNF mutant mice showed impaired learning in the Morris Water Maze.The mice did not present altered sensory processing and gating, measured by the acoustic startle response, nor did they show any alterations in basal anxiety measurements An NMDA receptor antagonist blocked the increase in the number of BDNF immune reactive hippocampal neurons following fear conditioning and impaired contextual fear learning Ou et al. (2007) 77 Animals (Rats) Administration of actinomycin D or anisomycin blocked fear conditioning and inhibited a conditioning-induced increase in BDNF.Inhibitors for N-methyl-D-aspartate (NMDA) receptor, L-type voltage-dependent calcium channel (L-VDCC), adenylyl cyclase, cAMP-dependent protein kinase (PKA), and calcium/calmodulin-dependent kinase IV (CaMKIV) significantly reduced the increase Jones et al. (2007) 78 Animals (Mice) Mice exposed to trials of unpaired or paired odours and footshocks, showed increased BDNF mRNA expression in the olfactory bulb and anterior piriform cortex when stimuli were unpaired and additionally in the posterior piriform cortex and basolateral amygdala when stimuli were paired Moretti et al. (2006) 79 Animals (Mice) BDNF expression remained unaltered in an animal model of Rett Syndrome that presents memory and learning deficits Aguilar-Valles et al. (2005) 80 Animals (Rats) Increased BDNF gene expression was observed in the hippocampus in response to stress produced by the Morris water-maze paradigm Alonso et al. (2005) 81 Animals (Rats) BDNF expression in the parietal cortex was shown to be essential for both short-term memory and long-term memory formation of inhibitory avoidance learning Chourbaji et al. (2004) 82 Animals (Mice) Mice with a 60% reduction in BDNF expression due to heterozygous gene disruption showed unchanged levels of monoamines, together with normal performance in behavioural tests that investigated anxiety and fear-associated learning.In these mice, choline acetyltransferase activity was significantly reduced in the hippocampus J Bras Psiquiatr.2016;65(3):251-61.